News

Promising DNA vaccine for Alzheimer’s moves closer to human trials

November 21, 2018 /

MATR Sponsor (view all)

The MDT Disadvantaged Business Enterprise (DBE) Program encourages and supports the participation of companies owned and controlled by socially and economically disadvantaged individuals in transportation contracts.

Researchers may be one step closer to finding the holy grail of potential Alzheimer’s treatments – a single-dose vaccine that prevents the onset of the disease. A new study from the University of Texas Southwestern Medical Center has revealed a novel DNA vaccine has been shown to successfully reduce the accumulation of two toxic proteins associated with the progression of Alzheimer’s disease.

Rich Haridy

https://newatlas.com/alzheimers-dna-vaccine-success-animal-studies/57325/?utm_medium=email&utm_campaign=2018-11-21%20153207%20USA%20Daily%20Basic%202018-11-21%20154235%20Scientists%20find%20way%20to%20melt%20gold%20at%20room%20temperature&utm_content=2018-11-21%20153207%20USA%20Daily%20Basic%202018-11-21%20154235%20Scientists%20find%20way%20to%20melt%20gold%20at%20room%20temperature+CID_bd45c4baa8f514e1b9161ca2eacb4930&utm_source=Campaign%20Monitor&utm_term=Read%20more